Clinical Trial: The Application of Transcriptomics in the Treatment of Ulcerative Colitis With Ustekinumab
Study Status: Completed
Recruit Status: RECRUITING
Condition: Ulcerative Colitis
Study Type: OBSERVATIONAL
Official Title: The Application of Transcriptomics for Establishing Potential Prognostic Markers of Response to Treatment of Ulcerative Colitis With Ustekinumab
Brief Summary:
The investigators hope that the present study will highlight new transcriptomic prognostic markers of response to Ustekinumab with the ultimate goal of individualizing treatment and making a more targeted selection of UC patients who will benefit from this biological agent.
Read more